Condition:   Infantile Hemangiomas
Intervention:  
Sponsors:   Children's Hospital Medical Center, Cincinnati;   Society for Pediatric Dermatology
Enrolling by invitation - verified May 2013

Condition:   Occupational; Cramp(s)
Intervention:   Drug: Propranolol
Sponsor:   Mayo Clinic
Recruiting - verified January 2014

Conditions:   Male Breast Cancer;   Recurrent Melanoma;   Stage IV Breast Cancer;   Stage IV Melanoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions:   Drug: propranolol hydrochloride;   Other: Correlative Studies
Sponsors:   Ohio State University Comprehensive Cancer Center;   William Carson
Not yet recruiting - verified December 2013

Condition:   Retinopathy of Prematurity
Intervention:   Drug: Propranolol eye drops
Sponsor:   Azienda Ospedaliero, Universitaria Meyer
Recruiting - verified December 2013

Condition:   Sickle Cell Disease
Intervention:   Drug: propranolol
Sponsors:   University of Miami;   Duke University
Recruiting - verified December 2013

Conditions:   Stages III Skin Melanoma;   Stages II Skin Melanoma;   Stage IB Skin Melanoma
Interventions:   Drug: Propranolol hydrochloride;   Drug: Placebo pill
Sponsor:   University Hospital, Geneva
Not yet recruiting - verified November 2013

Condition:   Postural Tachycardia Syndrome
Interventions:   Drug: Placebo;   Drug: Modafinil;   Drug: Propranolol
Sponsor:   Vanderbilt University
Recruiting - verified November 2013

Condition:   Cocaine Dependent Subjects
Interventions:   Drug: cocaine hydrochloride;   Drug: propranolol;   Drug: placebo
Sponsor:   Yale University
Active, not recruiting - verified October 2013

Condition:   Burn
Interventions:   Drug: Propranolol;   Drug: Placebo
Sponsors:   The University of Texas, Galveston;   The University of Texas, Galveston;   Shriners Hospitals for Children
Not yet recruiting - verified September 2013

Condition:   Cervical Cancer
Interventions:   Drug: Propranolol;   Behavioral: Diary;   Behavioral: Relaxation Audio Recording;   Behavioral: Questionnaires
Sponsors:   M.D. Anderson Cancer Center;   M.D. Anderson Cancer Center
Not yet recruiting - verified July 2013

Conditions:   Liver Cirrhosis;   Portal Hypertension
Interventions:   Drug: Rifaximin + propranolol;   Drug: Propranolol + Placebo
Sponsors:   Yonsei University;   Yonsei University
Not yet recruiting - verified July 2013

Condition:   Prostatic Neoplasms
Interventions:   Drug: VT-122;   Drug: Placebo
Sponsors:   Vicus Therapeutics;   Vicus Therapeutics
Not yet recruiting - verified May 2013

Condition:   Locally Advanced Breast Cancer
Interventions:   Drug: Propranolol;   Other: Breast imaging - Diffuse Optical Tomography (DOT)
Sponsors:   Columbia University;   Columbia University
Recruiting - verified May 2013

Condition:   Cocaine Addiction
Interventions:   Drug: Propranolol;   Drug: Placebo
Sponsors:   Medical University of South Carolina;   Medical University of South Carolina
Not yet recruiting - verified April 2013

Conditions:   Insulin Sensitivity;   Obesity
Interventions:   Other: Cold exposure;   Other: Cold exposure plus propranolol;   Other: Thermoneutral Conditions;   Other: Cold water consumption;   Other: Tepid water consumption;   Other: Exercise;   Other: Meal consumption
Sponsors:   The University of Texas, Galveston;   The University of Texas, Galveston
Recruiting - verified February 2013

Condition:   Anxiety
Interventions:   Drug: Clonidine;   Drug: Propranolol;   Drug: Placebo
Sponsors:   CES University;   CES University
Recruiting - verified February 2013

Conditions:   Liver Cirrhosis;   Portal Hypertension
Intervention:  
Sponsors:   Hospital Clinic of Barcelona;   Hospital Clinic of Barcelona
Completed - verified December 2012

Condition:   Hemangioma
Interventions:   Drug: Acebutolol;   Drug: Propanolol
Sponsors:   University Hospital, Montpellier;   University Hospital, Montpellier
Recruiting - verified November 2012

Condition:   Post-traumatic Stress Disorder
Interventions:   Drug: Propranolol;   Other: Trauma reactivation;   Drug: placebo
Sponsors:   University Hospital, Toulouse;   University Hospital, Toulouse
Not yet recruiting - verified October 2012

Conditions:   Metastatic Malignant Melanoma;   Unresectable Malignant Melanoma
Interventions:   Drug: Bevacizumab;   Drug: Propranolol;   Drug: Enalapril;   Drug: Dacarbazine
Sponsors:   Haukeland University Hospital;   Haukeland University Hospital;   The Norwegian Melanoma Group;   The Norwegian Cancer Association
Not yet recruiting - verified October 2012